|
8-K: Regulation FD Disclosure
On September 14, 2026, Kairos Pharma, Ltd., a Delaware corporation (the “Company”), issued a new investor presentation, which will be published on the Company’s website, www.kairospharma.com, and presented at the H.C. Wainwright 28th Ann...
|